- Celiac Disease & Gluten Intolerance Research
Celiac Disease & Gluten Intolerance Research
A team of researchers recently set out to assess the benefits of a gluten-free diet for people whose blood screens show markers for celiac disease, but who show no physical symptoms.
A new drug designed to prevent gluten uptake in the gut is showing some promise for the treatment of celiac disease.
Are hookworms the future of celiac disease treatment? Patients in Australia have shown a major improvement in gluten tolerance after receiving experimental hookworm treatments.
What’s potential celiac disease, and what happens to kids who have it and continue to eat a gluten-containing diet?
Can antibiotic exposure in pregnancy increase the risk of celiac disease in children? Some researchers suspect that infant microbiota play a pathogenic role in celiac disease. The idea that antibiotic treatment in pregnancy could significantly impact the infant microbiota, and thus influence the development of celiac disease, has led many to ponder the possible connection.
In this third study by researcher Peter Gibson at Monash University in Canada, he set out to assess patients claiming to have non-celiac gluten sensitivity.
A study establishing the existence of non-celiac gluten sensitivity has been turned on its head; by the very scientist who conducted it. In 2011, a small but scientifically rigorous study found that dietary gluten can trigger gastrointestinal distress in people without celiac disease. That study was conducted by Peter Gibson at Monash University in Australia.
A research team recently set out to explore the diversity of the cultivable human gut microbiome involved in gluten metabolism.
One angle being tried by researchers to treat celiac disease involves oral peptides that would prevent an adverse gluten reaction in people with celiac disease who are following a gluten-free diet.
People with non-celiac gluten sensitivity (NCGS) do not have celiac disease, but their symptoms improve when they are placed on gluten-free diets.
A research team recently set out to determine the risk of celiac disease autoimmunity and celiac disease, by age and by halpotype, in children.
Each year, non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, acetaminophen, and aspirin, send more than 100,000 people to the hospital, and cause over 16,000 deaths. These drugs are marketed under brand names such as Advil, Tylenol, and Bayer, among others.
A team of researchers recently set out to determine if T-cell receptor recognition of HLA-DQ2–gliadin complexes was connected with celiac disease.
Differentiating between celiac disease and non-celiac gluten sensitivity is often challenging. A team of researchers recently set out to assess the best way to tell the difference between the two.
Celiac disease guidelines suggest that some patients with high anti-tTG ab levels might be diagnosed without biopsy.
Drug would protect celiacs on a gluten-free diet against gut damage from small amounts of gluten contamination.
A team of Canadian researchers have discovered a key molecule that could lead to new treatments for celiac disease.
A team of researchers recently set out to assess if patient-centered barriers have a role in stifling serologic screening for celiac disease in individuals from high-risk populations.
Current treatment for celiac disease is to eat only foods which are gluten-free. But, what about foods processed to remove gluten? Is it safe for people with celiac disease to eat foods that have been processed to remove gluten?
Autophagy protein LC3 has recently been implicated in autoantigen formation. However, its role in celiac disease has remained unknown. A new study changes that.